Skip to main content

UBS Group AG

Position in AZN — Astrazeneca PLC

CIK 1610520 ZURICH, V8

Position in AZN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,004,504,738
-$175,149,134 QoQ
Shares Held
5,297,462
-11.4% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#39
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in AZN Over Time

Shares Held

Position Value (USD)

Derivatives in AZN

reported options exposure · as of Jun 30, 2026
CallValue
$15,956,712
CallShares
84,151
PutValue
$10,846,264
PutShares
57,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. AZN ranks #6 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 AZN
Astrazeneca PLC
This page
5,297,462 $1,004,504,738

All Filings in AZN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,956,712 84,151
2026-06-30 $10,846,264 57,200
2026-06-30 $1,004,504,738 5,297,462
2026-03-31 $31,002,984 157,200
2026-03-31 $31,387,760 159,151
2026-03-31 $1,179,653,872 5,981,411